Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64751 - 64775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	ACTA2	59	downregulated	resveratrol results in decreased expression of ACTA2 mRNA	10q23.31	A23849 A23850 A23851
Resveratrol	Investigational	ACYP1	97	upregulated	resveratrol results in increased expression of ACYP1 mRNA	14q24.3	A21103
Resveratrol	Investigational	ADGRE5	976	downregulated	resveratrol results in decreased expression of ADGRE5 mRNA	19p13.12	A22769
Resveratrol	Investigational	AFTPH	54812	downregulated	resveratrol results in decreased expression of AFTPH mRNA	2p14	A23852
Resveratrol	Investigational	AHR	196	upregulated	resveratrol results in increased expression of AHR mRNA	7p21.1	A23853
Resveratrol	Investigational	AKT1	207	downregulated	resveratrol results in decreased expression of AKT1 mRNA	14q32.33	A20233
Resveratrol	Investigational	AKT2	208	downregulated	resveratrol results in decreased expression of AKT2 mRNA	19q13.2	A22435
Resveratrol	Investigational	AKT3	10000	downregulated	resveratrol results in decreased expression of AKT3 mRNA	1q43-q44	A23854
Resveratrol	Investigational	ALDH1A3	220	downregulated	resveratrol results in decreased expression of ALDH1A3 mRNA	15q26.3	A21310
Resveratrol	Investigational	ALDH2	217	upregulated	resveratrol results in increased expression of ALDH2 mRNA	12q24.12	A22549
Resveratrol	Investigational	ALDOC	230	upregulated	resveratrol results in increased expression of ALDOC mRNA	17q11.2	A23855
Resveratrol	Investigational	ALG9	79796	downregulated	resveratrol results in decreased expression of ALG9 mRNA	11q23.1	A22289
Resveratrol	Investigational	AMOTL1	154810	upregulated	resveratrol results in increased expression of AMOTL1 mRNA	11q21	A23856
Resveratrol	Investigational	ANLN	54443	downregulated	resveratrol results in decreased expression of ANLN mRNA	7p14.2	A23857
Resveratrol	Investigational	ANLN	54443	upregulated	resveratrol results in increased expression of ANLN mRNA	7p14.2	A21103
Resveratrol	Investigational	ANO1	55107	upregulated	resveratrol results in increased expression of ANO1 mRNA	11q13.3	A22289
Resveratrol	Investigational	ANXA2	302	upregulated	resveratrol results in increased expression of ANXA2 mRNA	15q22.2	A23856
Resveratrol	Investigational	APAF1	317	downregulated	resveratrol results in decreased expression of APAF1 mRNA	12q23.1	A22498
Resveratrol	Investigational	APAF1	317	upregulated	resveratrol results in increased expression of APAF1 mRNA	12q23.1	A23847
Resveratrol	Investigational	API5	8539	downregulated	resveratrol results in decreased expression of API5 mRNA	11p12	A23847
Resveratrol	Investigational	APOC1	341	upregulated	resveratrol results in increased expression of APOC1 mRNA	19q13.32	A23852
Resveratrol	Investigational	APOE	348	upregulated	resveratrol results in increased expression of APOE mRNA	19q13.32	A22289
Resveratrol	Investigational	AQP1	358	upregulated	resveratrol results in increased expression of AQP1 mRNA	7p14.3	A21627
Resveratrol	Investigational	AQP3	360	upregulated	resveratrol results in increased expression of AQP3 mRNA	9p13.3	A21627 A23744
Resveratrol	Investigational	AR	367	downregulated	resveratrol results in decreased expression of AR mRNA	Xq12	A23260 A23857 A21627 A23747

Displaying entries 64751 - 64775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability